Chemoprevention in bladder cancer: What's new?

PubWeight™: 0.79‹?›

🔗 View Article (PMC 2792454)

Published in Can Urol Assoc J on December 01, 2009

Authors

Jean-Baptiste Lattouf1

Author Affiliations

1: Department of Surgery, Urologic Oncology Section and Minimally Invasive Section, University of Montréal Health Centre (CHUM), Montréal, QC.

Articles cited by this

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med (2004) 17.79

Fluid intake and the risk of bladder cancer in men. N Engl J Med (1999) 2.93

Prospective study of toenail selenium levels and cancer among women. J Natl Cancer Inst (1995) 1.85

Randomized prospective phase III trial of difluoromethylornithine vs placebo in preventing recurrence of completely resected low risk superficial bladder cancer. J Urol (2006) 1.64

Urinary system. Cancer (1995) 1.58

Non-steroidal anti-inflammatory drugs and bladder cancer prevention. Br J Cancer (2000) 1.46

Intake of vegetables, fruits, beta-carotene, vitamin C and vitamin supplements and cancer incidence among the elderly: a prospective study. Br J Cancer (1992) 1.39

Cyclooxygenase-2 expression is up-regulated in transitional cell carcinoma and its preneoplastic lesions in the human urinary bladder. Clin Cancer Res (2000) 1.30

Prospective study of dietary supplements, macronutrients, micronutrients, and risk of bladder cancer in US men. Am J Epidemiol (2000) 1.26

Comparisons of placebo, pyridoxine, and topical thiotepa in preventing recurrence of stage I bladder cancer. Urology (1977) 1.22

Diet and bladder cancer: a meta-analysis of six dietary variables. Am J Epidemiol (2000) 1.21

Dietary soy and increased risk of bladder cancer: the Singapore Chinese Health Study. Cancer Epidemiol Biomarkers Prev (2002) 1.20

Selenium, lycopene, alpha-tocopherol, beta-carotene, retinol, and subsequent bladder cancer. Cancer Res (1989) 1.17

Vitamin A supplements, fried foods, fat and urothelial cancer. A case-referent study in Stockholm in 1985-87. Int J Cancer (1990) 1.16

Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas. Am J Pathol (2000) 1.12

Nutrient intake in relation to bladder cancer among middle-aged men and women. Am J Epidemiol (1996) 1.11

The potential of soybean foods as a chemoprevention approach for human urinary tract cancer. Clin Cancer Res (2000) 1.06

Comparative chemopreventive mechanisms of green tea, black tea and selected polyphenol extracts measured by in vitro bioassays. Carcinogenesis (2000) 1.05

Megadose vitamins in bladder cancer: a double-blind clinical trial. J Urol (1994) 1.02

Diet and bladder cancer in Spain: a multi-centre case-control study. Int J Cancer (1991) 1.02

Fluid consumption and the risk of bladder cancer: results of a multicenter case-control study. Int J Cancer (2001) 1.00

Inhibition of bladder tumor growth by the green tea derivative epigallocatechin-3-gallate. J Urol (2003) 0.99

Vitamin C and vitamin E supplement use and bladder cancer mortality in a large cohort of US men and women. Am J Epidemiol (2002) 0.95

Carotenoids/vitamin C and smoking-related bladder cancer. Int J Cancer (2004) 0.92

Case-control study of urinary bladder cancer in metropolitan Nagoya. Natl Cancer Inst Monogr (1985) 0.91

Dietary factors in cancer of the lower urinary tract. Int J Cancer (1991) 0.89

Coffee consumption and bladder cancer in nonsmokers: a pooled analysis of case-control studies in European countries. Cancer Causes Control (2000) 0.88

Tea consumption and risk of bladder and kidney cancers in a population-based case-control study. Am J Epidemiol (2000) 0.88

Drinking, micturition habits, and urine concentration as potential risk factors in urinary bladder cancer. J Natl Cancer Inst (1987) 0.87

Adjuvant treatment with a vitamin A analogue (etretinate) after transurethral resection of superficial bladder tumors. Final analysis of a prospective, randomized multicenter trial in Switzerland. Eur Urol (1995) 0.83

13-cis-retinoic acid in chemoprevention of superficial bladder cancer. The National Bladder Cancer Group. J Cell Biochem Suppl (1992) 0.82

Randomized trial of fenretinide in superficial bladder cancer using DNA flow cytometry as an intermediate end point. Cancer Epidemiol Biomarkers Prev (2000) 0.81

Antitumor effect of ascorbic acid, lysine, proline, arginine, and green tea extract on bladder cancer cell line T-24. Int J Urol (2006) 0.81

Tryptophan metabolites, pyridoxine (vitamin B6) and their influence on the recurrence rate of superficial bladder cancer. Results of a prospective, randomised phase III study performed by the EORTC GU Group. EORTC Genito-Urinary Tract Cancer Cooperative Group. Eur Urol (1995) 0.80

Bladder cancer clinical trials. Urol Oncol (2005) 0.80

Effects of fruit juices, processed vegetable juice, orange peel and green tea on endogenous formation of N-nitrosoproline in subjects from a high-risk area for gastric cancer in Moping County, China. Eur J Cancer Prev (1993) 0.79

Correlation analysis between bladder cancer and cigarette smoking in various countries. Tohoku J Exp Med (1996) 0.76